0001567619-22-001304.txt : 20220119
0001567619-22-001304.hdr.sgml : 20220119
20220119114233
ACCESSION NUMBER: 0001567619-22-001304
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220117
FILED AS OF DATE: 20220119
DATE AS OF CHANGE: 20220119
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Oki Mark K
CENTRAL INDEX KEY: 0001491847
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38247
FILM NUMBER: 22537488
MAIL ADDRESS:
STREET 1: C/O ALEXZA PHARMACEUTICALS INC
STREET 2: 2091 STIERLIN COURT
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AYTU BIOPHARMA, INC
CENTRAL INDEX KEY: 0001385818
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 470883144
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 373 INVERNESS PARKWAY
STREET 2: SUITE 206
CITY: ENGLEWOOD
STATE: CO
ZIP: 80112
BUSINESS PHONE: (720) 437-6580
MAIL ADDRESS:
STREET 1: 373 INVERNESS PARKWAY
STREET 2: SUITE 206
CITY: ENGLEWOOD
STATE: CO
ZIP: 80112
FORMER COMPANY:
FORMER CONFORMED NAME: AYTU BIOSCIENCE, INC
DATE OF NAME CHANGE: 20150609
FORMER COMPANY:
FORMER CONFORMED NAME: AYTU BIOSCIENCE, INC.
DATE OF NAME CHANGE: 20150609
FORMER COMPANY:
FORMER CONFORMED NAME: Rosewind CORP
DATE OF NAME CHANGE: 20070110
4
1
doc1.xml
FORM 4
X0306
4
2022-01-17
0
0001385818
AYTU BIOPHARMA, INC
AYTU
0001491847
Oki Mark K
C/O AYTU BIOPHARMA, INC.
373 INVERNESS PARKWAY, SUITE 206
ENGLEWOOD
CO
80112
0
1
0
0
Chief Financial Officer
Common Shares
2022-01-17
4
A
0
100000
0
A
100000
D
Restricted share grant. One-third of the restricted shares shall vest on January 17, 2023; the remaining restricted shares shall vest quarterly thereafter, at 1/12th of the original grant, with full vesting on January 17, 2025.
/s/ Josh Disbrow as attorney-in-fact for Mark K. Oki
2022-01-18